MSD – known as Merck & Co in the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has been ...

The Medscape Global team is bringing their leading cardiology education and proven impact to the European Society of ...

Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new president and chief executive officer (CEO).

It is hoped the new formulation will offer patients greater freedom and flexibility compared to the liquid version ...

In response, medical communications planning has become increasingly integrated, allowing customised user experiences across ...

This Phase III global clinical trial for patients with either stage IIIB or IV unresectable melanoma involved 118 research ...

AstraZeneca (AZ) has announced that Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) has been recommended by ...

Patient engagement is one of the most reliable ways to drive long-term health outcomes and a critical benchmark for ...

Rezpegaldesleukin, which has already been granted FDA fast track designation for moderate-to-severe atopic dermatitis, is ...

The European Medicines Agency’s human medicines committee has recommended that BeOne Medicines’ Tevimbra (tislelizumab) be ...

Inclusion isn’t just about eligibility; it’s about participation Trials often demand time, travel and flexibility, resources ...

Eli Lilly has shared positive top-line results from a head-to-head study of its non-covalent Bruton’s tyrosine kinase (BTK) ...